You have to remember that since the original RTO of Bone Medical at 2 cents - the stock has returned some 600%.
Some folk are obviously going to take profit, the money is not made in the daily movement or the trade in companies like these. It is made with the growth in the story.
Like most BIO's an announcement from Pfizer or something or Roche being linked here (wouldn't that be nice) would bring you another 5-10 bags from these levels.
Matt Callahan knows how to return money and reward investors.
https://thewest.com.au/news/wa/perth-biotech-sells-for-60m-ng-ya-171304
"Iroko is understood to have paid $60 million under the deal, crystallising a 10-fold return for iCeutica's seed investors"
This project is on a much larger and grander scale. Very exciting company to be involved with.
We await.
Add to My Watchlist
What is My Watchlist?
